Abstract:The high prevalence of obesity and obesity-related comorbidities has reached pandemic proportions, particularly in Western countries. Obesity increases the risk to develop several chronic noncommunicable disease, ultimately contributing to reduced survival. Recently, obesity has been recognized as major risk factor for coronavirus disease-19 (COVID-19)-related prognosis, contributing to worse outcomes in those with established COVID-19. Particularly, obesity has been associated with higher hospitalization rates in acute or intensive care and greater risk for invasive mechanical ventilation than lean people. Obesity is characterized by metabolic impairments and chronic low-grade systemic inflammation that causes a pro-inflammatory microenvironment, further aggravating the cytokine production and risk of cytokine storm response during Sars-Cov2 sepsis or other secondary infections. Moreover, the metabolic dysregulations are closely related to an impaired immune system and altered response to viral infection that can ultimately lead to a greater susceptibility to infections, longer viral shedding and greater duration of illness and severity of the disease. In individuals with obesity, maintaining a healthy diet, remaining physically active and reducing sedentary behaviors are particularly important during COVID-19-related quarantine to reduce metabolic and immune impairments. Moreover, such stategies are of utmost importance to reduce the risk for sarcopenia and sarcopenic obesity, and to prevent a reduction and potentially even increase cardiorespiratory fitness, a well-known independent risk factor for cardiovascular and metabolic diseases and recently found to be a risk factor also for hospitalizations secondary to COVID-19. Such lifestyle strategies may ultimately reduce morbility and mortality in patients with infectious disease, especially in those with concomitant obesity. The aim of this review is to discuss how obesity might increase the risk of COVID-19 and potentially affect its prognosis once COVID-19 is diagnosed. We therefore advocate for implementation of strategies aimed at preventing obesity in the first place, but also to minimize the metabolic anomalies that may lead to a compromized immune response and chronic low-grade systemic inflammation, especially in patients with COVID-19.

Obesity is Associated with Severe Forms of COVID‐19

Obesity is Associated with Increased Severity of Disease in COVID-19 Pneumonia: a Systematic Review and Meta-Analysis

Obesity is Associated with Worse Outcomes in COVID‐19: Analysis of Early Data from New York City

Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019

Obesity population at risk of COVID-19 complications

Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations

Obesity aggravates COVID-19: An updated systematic review and meta-analysis

Obesity as a predictor for a poor prognosis of COVID-19: A systematic review

High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation

Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID‐19

Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics

Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management

Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships

Obesity and COVID‐19: An Italian Snapshot

Obesity as a risk factor for COVID-19: an overview

Obesity and age are transmission risk factors for SARS-CoV-2 infection among exposed individuals

Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China

Obesity Is Associated with Attenuated Tissue Immunity in COVID-19

Obesity and COVID-19 in Adult Patients With Diabetes

Obesity is a potential risk factor contributing to clinical manifestations of COVID-19